距舟楔与距舟关节融合治疗Müller-Weiss病的近期疗效
DOI:
作者:
作者单位:

济宁医学院附属医院

作者简介:

通讯作者:

中图分类号:

基金项目:


Short-term efficacy of talisnave-wedge fusion and talonavicular joint fusion in the treatment of Muller-Weiss disease
Author:
Affiliation:

Affiliated Hospital of Jining Medical College

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    摘要 目的 回顾性分析距舟楔与距舟关节融合治疗Müller-Weiss病的近期疗效。方法 回顾性分析2015年3月至2019年8月收治的17例(25足)Müller-Weiss病患者的数据资料,其中距舟楔关节融合术治疗16足,距舟关节融合术治疗9足。观察两组患者术后中足功能评分及相关影像学参数变化,包括Tomeno-Méary角、内弓角、跟骨倾斜角。结果 两组患者距舟楔融合组手术时间及自体髂骨植骨例数均显著大于距舟融合组,差异有统计学意义(P<0.01)。17例患者均获得随访,随访时间平均12.37±3.24个月。所有患者均获得骨性愈合,愈合时间平均10.37±5.16周。两组患者末次随访时,距舟楔融合组AOFAS评分及VAS评分优于距舟融合组,差异亦有统计学意义(P<0.05)。两组患者术前的TMA、MLAA、CPA比较,差异无统计学意义,术后均显著优于术前,差异有统计学意义(P<0.001)。其中距舟楔融合组TMA、MLAA、CPA优于距舟融合组,差异有统计学意义(P<0.05)。结论 距舟楔关节融合治疗Müller-Weiss病Ⅲ-Ⅳ期患者,术后近期临床效果优于距舟关节融合。

    Abstract:

    Abstract: Objective To retrospectively analyze the short-term efficacy of talisnave-wedge joint fusionand talonavicular joint fusion in the treatment of Muller-Weiss disease.MethodsThe data of 17 patients (25 feet) with Muller-Weiss disease admitted from March 2015 to August 2019 were retrospectively analyzed, of which 16 feet were treated with talisnave-wedge joint fusion and 9 feet were treated with talonavicular joint fusion. Postoperative midfoot function American Orthopaedic Foot and Ankle Society(AOFAS) and related imaging parameters, including Tomeno-Meary Angle, medial longitudinal arch angle(MLAA)and calcaneal pitch angle(CPA)were observed in 2 groups.Results The operative time and the number of autogenous iliac bone grafts in talonavicular wedge fusion group were significantly higher than talonavicular fusion group (P<0.01).All the 17 patients were followed up for an average of 12.37±3.24 months. All patients had bony healing with a mean healing time of 10.37±5.16 weeks.At the last follow-up, the AOFAS score and VAS score in the talisnave-wedge fusion group were better than that in the talisnave-wedge fusion group (P<0.05).There were no statistically significant differences in TMA, MLAA and CPA between the two groups before operation, but postoperative TMA, MLAA and CPA were significantly better than preoperation (P<0.001). TMA, MLAA and CPA in talisnave-wedge group were better than those in the talonavicular joint fusion group (P<0.05).Conclusion Talisnave-wedge fusion is better than talonavicular joint fusion in treating the Muller Weiss disease Ⅲ- Ⅳ period patients.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-01-29
  • 最后修改日期:2021-04-13
  • 录用日期:2021-05-06
  • 在线发布日期:
  • 出版日期: